A pilot phase II study of estradiol [TX-004HR] in postmenopausal women with vulvar and vaginal atrophy
Phase of Trial: Phase II
Latest Information Update: 22 Sep 2016
At a glance
- Drugs Estradiol (Primary)
- Indications Atrophic vaginitis
- Focus Therapeutic Use
- 22 Sep 2016 According to a TherapeuticsMD media release, data of this trial will be presented at annual meetings of the International Menopause Society (IMS) and the North American Menopause Society (NAMS), 2016.
- 09 Mar 2015 Results published in TherapeuticsMD media release.
- 09 Mar 2015 Results were presented at the Endocrine Society's 97th Annual Meeting & Expo in March 2015, according to a TherapeuticsMD media release.